Latest filing published 28 Jun 2023 for DiaMedica Therapeutics Inc., €3.5M.
Insider track record
No signal scores available.
Jennie Gustafsson: trading record in brief
Jennie Gustafsson discloses dealings in DiaMedica Therapeutics Inc. to SEC (Form 4). Altogether 2 filings, all relating to 23 June 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 28 June 2023, the filings show a transaction worth €3.5M in DiaMedica Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jennie Gustafsson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,470,588 shares@ CA$3.40100.0% of flowCommon SharesTSXSEDI:4148953
- Common SharesTSXSEDI:4148952
2 of 2 declarations